KMT2A and chronic myelogenous leukemia, BCR-ABL1 positive: They also offer molecular testing (PCR) to detect common fusion genes that are involved in haematological malignancies, such as the BCR-ABL fusion gene in chronic myeloid leukaemia (CML), BCR-ABL fusion gene, TEL-AML1 fusion gene, and E2A-PBX1 fusion gene and MLL gene rearrangement in acute lymphocytic leukaemia (ALL), and PML-RARA gene in acute promyelocytic leukaemia.